Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: multiple sclerosis,relapsing (Click to remove) Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis JAMA 32:175-187, Brown, J.W.L.,et al, 2019 Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review JNNP 84:420-426, La Mantia, L.,et al, 2013 Alemtuzumab for Multiples Sclerosis: Who and When to treat? Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012 How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS? Neurol 69:1498-1507, Brown,M.G.,et al, 2007 Mitoxantrone for Multiple Sclerosis in Clinical Practice Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004 The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis Neurol 61:1332-1338, Goodin,D.S.,et al, 2003 Relapses and Progression of Disability in Multiple Sclerosis NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000 Management of Multiple Sclerosis NEJM 337:1604-1611, Rudick,R.A.,et al, 1997 Showing articles 0 to 8 of 8